Pharmaceutical industry – Page 14
-
-
OpinionLooking beyond the next wave
We need to apply lessons from Covid-19 to tackle antimicrobial resistance and climate change
-
BusinessWhat are the risks of fast-tracking a Covid-19 vaccine?
Condensing timelines from years to months inevitably involves compromises
-
ArticleCatalysts for collaboration
Demand for greener, more sustainable technologies in pharma, agro and fine chemicals sectors is growing – catalysis is at the heart of this transformation
-
ArticleCatalysis and chemical bonds that make us stronger
Chemical and pharma industry is built on collaboration that draws on a wide range of expertise to develop innovative materials, compounds and components
-
BusinessScrambling and gambling to scale up Covid-19 medicines
Organisations work towards making billions of doses of products not yet proven to work
-
OpinionDragons of immunology
Anti-inflammatories like dexamethasone are triumphs amid the pitfalls of the immune system
-
NewsCovid-19 is forcing pharma to rethink clinical trials
Drug trials have become a casualty of Covid-19, but the pandemic is also prompting change
-
NewsUS chemical plants risk disastrous cyberattacks relying on guidance a decade out of date
Cybersecurity guidelines for chemical plants urgently need updating and inspectors need training, report finds
-
BusinessHow Covid-19 is changing drug manufacturing
Catalent is adapting, focusing on employee safety and supply chain security
-
BusinessThis little Crispr went to market
Gene editing technology heading towards commercial reality in pharmaceuticals, food and organ transplant
-
OpinionHopes and fears for remdesivir
Available resources for testing coronavirus treatments need to be used wisely
-
OpinionDoes the drug work, or not?
Coronavirus trials reveal the murky reality of disentangling compounds’ effects on human biology
-
BusinessMicropore Technologies’ model membranes make exact emulsions
Solving scalability issues to control particle size without high-shear mixing
-
-
BusinessPostEra points its synthesis algorithm at coronavirus
Mapping out drug discovery routes with artificial intelligence
-
BusinessMystery surrounds UK claim of Covid-19 test reagent ‘shortage’
Suppliers are stepping up production to meet demand as UK targets mass testing
-
OpinionVaccine development against the clock
How long will it take to develop a coronavirus vaccine and why is it so hard?
-
BusinessCan existing drugs slow Covid-19?
The fastest route to treatments may be to repurpose existing drugs – if they work
-
BusinessGetting ideas across
In a diverse industry like chemicals, we need to make sure we’re open to learning from unexpected angles.